Literature DB >> 15590120

Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat.

R E Williams1, E A Lock.   

Abstract

D-Serine causes selective necrosis to the straight portion of the rat renal proximal tubules. The onset is rapid, occurring within 3-4 h and accompanied by proteinuria, glucosuria and aminoaciduria. The metabolism of D-serine by D-amino acid oxidase (D-AAO) may be involved in the mechanism of toxicity. D-AAO is localized within the peroxisomes of renal tubular epithelial cells, which is also the location of D-serine reabsorption. To address the role of D-AAO in D-serine-induced nephrotoxicity, we have examined the effect of sodium benzoate (SB) on the renal injury. SB has been shown to be a potent, competitive inhibitor of kidney D-AAO in vitro. Male Alderley Park rats were exposed to D-serine (500 mg/kg i.p.) 1 h after exposure to SB (125, 250, 500 or 750 mg/kg i.p.). Urine was collected for 0-6 h, then terminal plasma samples and kidneys were taken at 6.5 h. A second group of animals was given SB (500 mg/kg) followed by D-serine (500 mg/kg i.p.; 1 h later) and urine was collected after 0-6, 6-24 and 24-48 h. Terminal plasma samples and kidneys were taken at 48 h. 1H NMR spectroscopic analysis of urine, combined with principal component analysis, demonstrated that SB was able to prevent D-serine-induced perturbations to the urinary profile in a dose dependent manner. This was confirmed by measurement of plasma creatinine and urinary glucose and protein and histopathological examination of the kidneys. Assessment 48 h after D-serine administration revealed that nephrotoxicity was observed in animals pre-treated with SB (500 mg/kg) although the extent of injury was less pronounced than following D-serine alone. These results demonstrate that whilst prior exposure to SB prevents the initial onset of D-serine-induced nephrotoxicity, renal injury is still apparent at later time points. D-AAO activity in the kidney was decreased by 50% 1 h after dosing with SB suggesting that inhibition of this enzyme may be responsible for the observed protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15590120     DOI: 10.1016/j.tox.2004.08.008

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  16 in total

1.  Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine.

Authors:  Jesse Alt; Camilo Rojas; Krystyna Wozniak; Ying Wu; Dana Ferraris; Takashi Tsukamoto; Barbara Slusher
Journal:  Anal Biochem       Date:  2011-08-16       Impact factor: 3.365

2.  D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.

Authors:  Camilo Rojas; Jesse Alt; Nancy A Ator; Ajit G Thomas; Ying Wu; Niyada Hin; Krystyna Wozniak; Dana Ferraris; Rana Rais; Takashi Tsukamoto; Barbara S Slusher
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

3.  Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.

Authors:  Chien-Yi Kuo; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  CNS Drugs       Date:  2022-10-04       Impact factor: 6.497

4.  Inhibition of D-amino-Acid oxidase activity induces pain relief in mice.

Authors:  Wenjuan Zhao; Ryuichi Konno; Xiang-Jun Zhou; Ming Yin; Yong-Xiang Wang
Journal:  Cell Mol Neurobiol       Date:  2007-09-15       Impact factor: 5.046

5.  Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase.

Authors:  James F Berry; Dana V Ferraris; Bridget Duvall; Niyada Hin; Rana Rais; Jesse Alt; Ajit G Thomas; Camilo Rojas; Kenji Hashimoto; Barbara S Slusher; Takashi Tsukamoto
Journal:  ACS Med Chem Lett       Date:  2012-09-16       Impact factor: 4.345

Review 6.  Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues.

Authors:  Larryn W Peterson; Charles E McKenna
Journal:  Expert Opin Drug Deliv       Date:  2009-04       Impact factor: 6.648

Review 7.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

8.  Nephrotoxicity induced by the R- and S-enantiomers of N-(3,5-dichlorophenyl)-2-hydroxysuccinimide (NDHS) and their sulfate conjugates in male Fischer 344 rats.

Authors:  Gary O Rankin; Dianne K Anestis; Monica A Valentovic; Hang Sun; William E Triest
Journal:  Toxicology       Date:  2007-07-20       Impact factor: 4.221

9.  Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.

Authors:  Rana Rais; Ajit G Thomas; Krystyna Wozniak; Ying Wu; Hanna Jaaro-Peled; Akira Sawa; Christine A Strick; Sandra J Engle; Nicholas J Brandon; Camilo Rojas; Barbara S Slusher; Takashi Tsukamoto
Journal:  Drug Metab Dispos       Date:  2012-07-26       Impact factor: 3.922

Review 10.  Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer.

Authors:  Gerson D Guercio; Rogerio Panizzutti
Journal:  Front Psychiatry       Date:  2018-02-05       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.